Breast cancer therapeutics market expands in Asia-Pacific: GBI Research
Japan had the largest market in 2013 with a share of 58 per cent, followed by China and Australia, with respective shares of 21…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
MDD therapeutics market to face dynamic phase up until 2023: Report
GlobalData report also reveals that the MDD treatment market achieved a sales of approximately $9.3 billion in 2013 across seven…
Issues with recent changes to clinical trials regulations
Bhavik Narsana, Partner, Sameer Sah, Principal Associate and Arijeet Mukherjee, Associate, Khaitan & Co aim to identify the…
Advantages and challenges of AV recording in clinical trials
Dr YK Gupta, Head Department of Pharmacology and Spokesperson AIIMS, and Lt Col (Dr) Prafull Mohan, Senior Resident, Department of…
In the line of fire
India’s IP laws have been in the eye of a storm since it issued its first ever Compulsory Licence. Will they land us into the list…
Why are Indian generics under attack? One view from America
Giving a view from America, Roger Bate shares his impressions on the quality of generic drugs in India and opines that the CDSCO,…
Thomson Reuters names 2014 leading drugs to watch
Analysis points to three potential blockbusters: Sovaldi, Anoro Ellipta and Idelalisib entering market this year
Patent protection losses will hinder HIV treatment market growth within seven years: GBI Research
The first-line antiretroviral therapies Atripla and Truvada will lose patent protection during the forecast period, which will…
‘Patient awareness on tuberculosis is a big gap’
Tuberculosis is a focused area of diagnostic research at Mumbai’s Hinduja Hospital which performs 30,000 TB culture tests…
’A demand for nutrition supplements has been seen amongst the Indians’
Haeri Roh-Schmidt, Head, Science & Innovation, HNH, APAC, DSM Nutritional Products, talks about the scope for nutritional…
Commercial Excellence 2.0
Bart Janssens, Partner and Director, BCG and Rahul Guha, Principal, BCG, in the third part of the article series, focus on people,…
India, China key prospects for interventional cardiac device manufacturers: Frost & Sullivan
Report says that manufacturers must expand capabilities and capacity through strategic partnerships in order to fulfill demand
MCD pharma market value in seven countries to increase to $6.4 bn by 2022: GlobalData
The US will show the highest growth in the MCD treatment market
Commercial Excellence 2.0
Bart Janssens, Partner and Director, BCG and Rahul Guha, Principal, BCG, in second part of the series, focus on the marketing…
Boom in smart pills will reach new peak by 2018-2020: Frost & Sullivan
Technological advances in minimally invasive and remote controlled devices drive the market
’We expect MNCs to bring in next generation products and improve accessibility’
Mahesh Singhi, Managing Director, Singhi Advisors shares his views and offers insights on the changing regulatory environment in…
Commercial Excellence 2.0
Bart Janssens, Partner and Director, BCG and Rahul Guha, Principal, BCG, in this three part article series, challenge some of the…
Bringing in the moolah
Regulatory concerns and adverse market conditions notwithstanding, the pharmaceutical industry in India continues to attract…
’Rating models are good indicators of corporate governance, not a solution’
Corporate governance has been the need of the hour for the pharmaceutical industry which has been plagued by a string of frauds.…
Wish list of policy changes
With the general elections around the corner, the Finance Minister will present a 'Vote of Accounts' rather than a budget. Even…